VRPX
Virpax Pharmaceuticals, Inc.
OTCHealthcareBiotechnologyUS
Company Profile
CEO
Jatinder Dhaliwal
IPO Date
2021-02-17
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
Virpax Pharmaceuticals, Inc.
CEO
Jatinder Dhaliwal
IPO Date
2021-02-17
Sector
Healthcare
Industry
Biotechnology
Exchange
OTC
Country
US
| 25,000 |
| $0.32 |
| 16 Aug 2023 | Shah Vinay | Chief Financial Officer | A-Award | Acquired | 100,000 | $0.99 |
| 21 Jun 2023 | Shah Vinay | Chief Financial Officer | A-Award | Acquired | 100,000 | $0.99 |
| 21 Jun 2023 | Shah Vinay | officer | Disposed | 0 | $0.00 |
| 4 Jan 2023 | Singh Vanila | director | A-Award | Acquired | 15,000 | $0.00 |
| 5 Jan 2022 | JACOB GARY S | director | A-Award | Acquired | 12,091 | $3.43 |
| 5 Jan 2022 | Singh Vanila | director | A-Award | Acquired | 12,091 | $3.43 |
| 9 Apr 2021 | JACOB GARY S | director | A-Award | Acquired | 13,183 | $4.62 |
| 9 Apr 2021 | Singh Vanila | director | A-Award | Acquired | 8,183 | $4.62 |